[1] SCHWARZ F, DERKS J, MONJE A, et al. Peri-implantitis. J Clin Periodontol. 2018; 45(Suppl 20):246-266.
[2] HERRERA D, BERGLUNDH T, SCHWARZ F, et al. Prevention and treatment of peri-implant diseases-The EFP S3 level clinical practice guideline. J Clin Periodontol. 2023;50(Suppl 26):4-76.
[3] SMEETS R, HENNINGSEN A, JUNG O, et al. Definition, etiology, prevention and treatment of peri-implantitis--a review. Head Face Med. 2014;10:34.
[4] RAMS TE, DEGENER JE, VAN WINKELHOFF AJ. Antibiotic resistance in human peri-implantitis microbiota. Clin Oral Implants Res. 2014;25(1):82-90.
[5] BESSA LJ, EGAS C, PIRES C, et al. Linking peri-implantitis to microbiome changes in affected implants, healthy implants, and saliva: a cross-sectional pilot study. Front Cell Infect Microbiol. 2025;15:1543100.
[6] RENVERT S, POLYZOIS I, CLAFFEY N. Surgical therapy for the control of peri-implantitis. Clin Oral Implants Res. 2012;23 (Suppl 6): 84-94.
[7] ITO H, MONOBE K, OKUBO S, et al. Identification of Novel Antimicrobial Compounds Targeting Mycobacterium tuberculosis S-Adenosyl-L-Homocysteine Hydrolase Using Dual Hierarchical In Silico Structure-Based Drug Screening. Molecules. 2024;29(6):1303.
[8] Health Organization (WHO). Global tuberculosis report 2024 (2024).
[9] LANGE C, AABY P, BEHR MA, et al. 100 years of Mycobacterium bovis bacille Calmette-Guérin. Lancet Infect Dis. 2022;22(1):2-12.
[10] PINA P, LEMOS C, DESOUSA S. A buccal mucosa ulcer as the first sign of tuberculosis. J Oral Maxillofac Pathol. 2022;26(3):399-403.
[11] MOMBELLI A, DECAILLET F. The characteristics of biofilms in peri-implant disease. J Clin Periodontol. 2011;38(11):203-213.
[12] BELIBASAKIS GN. Microbiological and immuno-pathological aspects of peri-implant diseases. Arch Oral Biol. 2014;59(1):66-72.
[13] 李志杰,王少果,李跃烘,等.高通量测序研究种植体周围炎龈下微生物多样性[J].四川大学学报(医学版),2015,46(4):568-572.
[14] DASILVA ES, FERES M, FIGUEIREDO LC, et al. Microbiological diversity of peri-implantitis biofilm by Sanger sequencing[J]. Clin Oral Implants Res. 2014;25(10):1192-1199.
[15] CASADO PL, OTAZU IB, BALDUINO A, et al. Identification of periodontal pathogens in healthy periimplant sites. Implant Dent. 2011;20(3):226-235.
[16] 文言,王宇蓝.菌斑生物膜与种植体周围炎相关研究进展[J].口腔疾病防治,2024,32(9):730-736.
[17] IUȘAN S, LUCACIU O, PETRESCU N, et al. The Main Bacterial Communities Identified in the Sites Affected by Periimplantitis: A Systematic Review. Microorganisms. 2022;10(6):1232.
[18] SAHRMANN P, GILLI F, WIEDEMEIER DB, et al. The Microbiome of Peri-Implantitis: A Systematic Review and Meta-Analysis. Microorganisms. 2020;8(5):661.
[19] 唐立新.结核病的病因学分析[J].中国中医药现代远程教育,2011,9(8):95.
[20] GAO X, ZHOU J, SUN X, et al. Diversity analysis of subgingival microbial bacteria in peri-implantitis in Uygur population. Medicine (Baltimore). 2018;97(5):9774.
[21] MOHANASUNDARAM A, GOHIL NV, ETEKOCHAY MO, et al. Mycobacterium tuberculosis : a new hitchhiker in the etiopathogenesis of periodontitis. Int J Surg. 2024;110(6):3606-3616.
[22] RASTOGI T, CHOWDHARY Z, KRISHNA MK, et al. Prevalence of periodontitis in patients with pulmonary disease: A cross-sectional survey in the industrial district of India. J Indian Soc Periodontol. 2019;23(3):269-274.
[23] JAVALI MA, PATIL V, AYESHA H. Periodontal disease as the initial oral manifestation of abdominal tuberculosis. Dent Res J (Isfahan). 2012;9(5):634-637.
[24] JAIN P, JAIN I. Oral Manifestations of Tuberculosis: Step towards Early Diagnosis. J Clin Diagn Res. 2014;8(12):18-21.
[25] DEBATA T, MOHAPATRA A, SAHU SR, et al. Rare case of extrapulmonary tuberculosis masquerading as an intraoral sinus in association with a nonhealing extraction socket in a teenage girl-”A case report with Review of literature”. J Oral Maxillofac Pathol. 2024;28(2):301-306.
[26] JAIN S, VIPIN B, KHURANA P. Gingival tuberculosis. J Indian Soc Periodontol. 2009; 13(2):106-108.
[27] WEIR MR, THORNTON GF. Extrapulmonary tuberculosis. Experience of a community hospital and review of the literature. Am J Med. 1985;79(4):467-478.
[28] LONČAR BRZAK B, HORVAT ALEKSIJEVIĆ L, VINDIŠ E, et al. Osteonecrosis of the Jaw. Dent J (Basel). 2023;11(1):23.
[29] EBENEZER J, SAMUEL R, MATHEW GC, et al. Primary oral tuberculosis: report of two cases. Indian J Dent Res. 2006;17(1):41-44.
[30] CAPODIFERRO S, LIMONGELLI L, FAVIA G. Oral and Maxillo-Facial Manifestations of Systemic Diseases: An Overview. Medicina (Kaunas). 2021;57(3):271.
[31] HAMID R, SHARMA P, SHEIKH RA, et al. Primary oral tuberculosis: A case series of a rare disease. J Oral Maxillofac Pathol. 2020;24(2):332-338.
[32] 冯林林,冯彦华.固有免疫细胞在结核分枝杆菌感染中的作用[J].微生物学免疫学进展, 2024,52(5):92-97.
[33] FORTUNE SM, SOLACHE A, JAEGER A, et al. Mycobacterium tuberculosis inhibits macrophage responses to IFN-gamma through myeloid differentiation factor 88-dependent and -independent mechanisms. J Immunol. 2004; 172(10):6272-6280.
[34] 张贺龙,付琳,刘晓宁,等.TNF-α基因多态性及红细胞沉降率、降钙素原水平对老年骶髂关节结核患者手术预后的影响[J].中国老年学杂志,2025,45(8):1869-1873.
[35] RAIMONDO A, BALESTRINO A, LEMBO S. PDE4 Inhibition Reduced Osteoclast Differentiation in Psoriatic Patients. Life (Basel). 2025;15(3):467.
[36] QIAN Y, YU Y, YANG F, et al. Jingui Shenqi Wan alleviates bone loss induced by primary osteoporosis by inhibiting osteoblast pyroptosis. J Orthop Surg Res. 2025;20(1):141.
[37] WOJDASIEWICZ P, PONIATOWSKI A, SZUKIEWICZ D. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis. Mediators Inflamm. 2014;2014:561459.
[38] SARAPULTSEV A, GUSEV E, KOMELKOVA M, et al. JAK-STAT signaling in inflammation and stress-related diseases: implications for therapeutic interventions. Mol Biomed. 2023;4(1):40.
[39] 尹昭懿,李效宇,王子璇,等.免疫反应在种植体周围炎中的作用研究进展[J]. 现代口腔医学杂志,2022,36(1):46-50.
[40] DUTZAN N, KAJIKAWA T, ABUSLEME L, et al. A dysbiotic microbiome triggers TH17 cells to mediate oral mucosal immunopathology in mice and humans. Sci Transl Med. 2018;10(463):0797.
[41] FRANCO C, PATRICIA HR, TIMO S, et al. Matrix Metalloproteinases as Regulators of Periodontal Inflammation. Int J Mol Sci. 2017;18(2):440.
[42] JIANG N, AN J, YANG K, et al. NLRP3 inflammasome: a new target for prevention and control of osteoporosis? Front Endocrinol. 2021;12:752546.
[43] TSUKASAKI M, TAKAYANAGI H. Osteoimmunology: evolving concepts in bone-immune interactions in health and disease[J]. Nat Rev Immunol. 2019; 19(10):626-642.
[44] GHIGHI M, LLORENS A, BAROUKH B, et al. Differences between inflammatory and catabolic mediators of peri-implantitis and periodontitis lesions following initial mechanical therapy: An exploratory study. J Periodontal Res. 2018; 53(1):29-39.
[45] ESPÉLI M, SMITH KG, CLATWORTHY MR. FcγRIIB and autoimmunity. Immunol Rev. 2016;269(1): 194-211.
[46] WEI S, LING D, ZHONG J, et al. Elk1 enhances inflammatory cell infiltration and exacerbates acute lung injury/acute respiratory distress syndrome by suppressing Fcgr2b transcription. Mol Med. 2024;30(1):53.
[47] TAKEGAHARA N, KIM H, CHOI Y. Unraveling the intricacies of osteoclast differentiation and maturation: insight into novel therapeutic strategies for bone-destructive diseases. Exp Mol Med. 2024;56(2):264-272.
[48] REN F, ZHENG S, LUO H, et al. Fibroblast derived C3 promotes the progression of experimental periodontitis through macrophage M1 polarization and osteoclast differentiation. Int J Oral Sci. 2025;17(1):30.
[49] FERNANDES MH, GOMES PS. Bone Cells Dynamics during Peri-Implantitis: a Theoretical Analysis. J Oral Maxillofac Res. 2016;7(3):6.
|